Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959593 · ClinicalTrials.gov registry record · NA
The Effects of Visior on Ocular Hemodynamics
A NA study of Primary Open Angle Glaucoma, sponsored by Visior Technologies.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT02959593: Completed NA study of Primary Open Angle Glaucoma, sponsored by Visior Technologies.
NCT02959593 is a NA study of Primary Open Angle Glaucoma that has completed, run by Visior Technologies. The registered enrollment target is 35 participants, below the 293-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02959593, a NA study of Primary Open Angle Glaucoma, has completed, sponsored by Visior Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.
Primary Outcome
retinal capillary blood flow in arbitrary units
Conditions Studied
Interventions
- DEVICE VISIOR video goggles
Study Locations (1)
Indiana
- Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02959593 record still lists
NCT02959593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 293-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which VISIOR video goggles is the first listed.
NCT02959593 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02959593 about?
NCT02959593 is a clinical study titled "The Effects of Visior on Ocular Hemodynamics". To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.
What is the current status of trial NCT02959593?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-01. Estimated completion is 2017-06.
What conditions does trial NCT02959593 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma.
What interventions are being tested in trial NCT02959593?
The interventions under investigation include: VISIOR video goggles (DEVICE).
Who is sponsoring clinical trial NCT02959593?
This trial is sponsored by Visior Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02959593 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02959593's enrollment target sits among peer trials
35 19th of 19 higher than 1 of 19 other Primary Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Primary Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hydrus® Microstent New Enrollment Post-Approval Study
RECRUITING · NA
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
COMPLETED · NA
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia